Registration No. 333-260471

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

Minerva Surgical, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

 

Delaware

 

26-3422906

(State or other jurisdiction of incorporation)

 

(I.R.S. Employer Identification No.)

 

 

 

4255 Burton Dr., Santa Clara, CA

95054

(Address of principal executive offices)

(Zip Code)

 

Minerva Surgical, Inc. 2008 Stock Plan
Minerva Surgical, Inc. 2021 Equity Incentive Plan
Minerva Surgical, Inc. 2021 Employee Stock Purchase Plan

(Full title of the plan)

 

Todd Usen

Copies to:

President and Chief Executive Officer

Joseph Wolfson

Minerva Surgical, Inc.

Sunjeet S. Gill

4255 Burton Dr.

Stevens & Lee, P.C.

Santa Clara, CA 95054

1500 Market Street, East Tower

(855) 646-7874

Philadelphia, PA 19102

(Name, address and telephone number, including area code, of agent for service)

(215) 575-0100

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ◻

Accelerated filer ◻

Non-accelerated filer

Smaller reporting company

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

This Registration Statement shall become effective upon filing in accordance with Rule 464 promulgated under the Securities Act of 1933, as amended.

 

DEREGISTRATION OF SHARES

 

The class of securities to which this Registration Statement on Form S-8 (File No. 333-260471) (the “Registration Statement”) relates is held by fewer than 300 shareholders of record. Minerva Surgical, Inc. (the “Company”) is filing this Post-Effective Amendment No. 1 to the Registration Statement to deregister all of the shares of common stock, $0.001 par value, of the Company, and related stock options therefor, registered under the Registration Statement that remain unissued under each of the Minerva Surgical, Inc. 2008 Stock Plan, the Minerva Surgical, Inc. 2021 Equity Incentive Plan and the Minerva Surgical, Inc. 2021 Employee Stock Purchase Plan.

 

 

 


 

SIGNATURES

 

The Registrant. Pursuant to the requirements of the Securities Exchange Act of 1933, as amended, the Registrant certifies that is has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Santa Clara, State of California, on December 26, 2023.

 

 

 

 

MINERVA SURGICAL, INC.

 

 

 

 

 

 

Date: December 26, 2023

/s/ Todd Usen

 

Todd Usen

 

President and Chief Executive Officer

 

(Duly Authorized Representative)

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date indicated.

 

 

 

 

 

By:

/s/ Uri Geiger

By:

/s/ Todd Usen

 

Uri Geiger

 

 

Todd Usen

 

Chairman of the Board of Directors

 

 

President and Chief Executive Officer

 

 

 

 

Director

 

 

 

 

(Principal Executive Officer)

 

 

 

 

 

Date: December 26, 2023

 

Date: December 26, 2023

 

 

 

 

 

By:

/s/ Joel Jung

 

By:

/s/ Ali Behbahani

 

Joel Jung

 

 

Ali Behbahani

 

Chief Financial Officer

 

 

Director

 

(Principal Financial and Accounting Officer)

 

 

 

 

 

 

 

 

Date: December 26, 2023

 

Date: December 26, 2023

 

 

 

 

 

By:

/s/ Daniel Cohen

 

By:

/s/ Catherine Coste

 

Daniel Cohen

 

 

Catherine Coste

 

Director

 

 

Director

 

 

 

 

 

Date: December 26, 2023

 

Date: December 26, 2023

 

 

 

 

 

By:

/s/ Niquette Hunt

 

By:

/s/ Derrick Sung

 

Niquette Hunt

 

 

Derrick Sung

 

Director

 

 

Director

 

 

 

 

 

Date: December 26, 2023

 

Date: December 26, 2023

 

 

 



Minerva Surgical (NASDAQ:UTRS)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Minerva Surgical.
Minerva Surgical (NASDAQ:UTRS)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Minerva Surgical.